Monique Bondil Van Niel

Title: Monique Bondil Van Niel: Innovator in Respiratory Disease Treatment

Introduction

Monique Bondil Van Niel is a prominent inventor based in Essex, SE. She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of respiratory diseases. With a total of 2 patents to her name, her work is paving the way for innovative therapies.

Latest Patents

Monique's latest patents focus on a pharmaceutical composition adapted for pulmonary administration by inhalation. One of her notable inventions describes a composition that includes a glitazone, such as pioglitazone or rosiglitazone, combined with one or more pharmaceutically acceptable carriers and/or excipients. The composition is characterized by having at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. This innovative approach aims to enhance the efficacy of respiratory disease treatments.

Career Highlights

Monique is currently associated with Pulmagen Therapeutics Limited, a company focused on inflammation-related therapies. Her expertise in pharmaceutical compositions has positioned her as a key player in the development of new treatments for respiratory conditions.

Collaborations

Monique has collaborated with notable colleagues, including Harry Finch and Craig Fox. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Monique Bondil Van Niel is a trailblazer in the pharmaceutical industry, particularly in the realm of respiratory disease treatment. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.